Barclays PLC Idera Pharmaceuticals, Inc. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.01 - $1.58 $12,516 - $19,580	-12,393 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.23 - $5.98 $15,243 - $74,110	12,393 New	12,393 $16,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $3.31 $82,540 - $128,871	-38,934 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.37 - $3.97 $79,489 - $133,153	33,540 Added 621.8%	38,934 $104,000
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $12,568 - $20,443	5,394 New	5,394 $14,000
Q4 2018 Feb 14, 2019	SELL	$2.77 - $9.38 $19,827 - $67,142	-7,158 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $39,583 - $81,314	7,158 New	7,158 $64,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.